ClouDr Group

ClouDr (智云健康) Pre-IPO - Strong Growth but Has Issues that Need to Be Clarified

Equity Capital Markets
203 Views, 20 Jan 2022 10:38
EXECUTIVE SUMMARY
  • ClouDr Group (16897333D CH) (CDG) is looking to raise up to US$500m in its upcoming Hong Kong IPO.
  • The firm is a digital chronic condition management solution provider and is market leader in China in terms of the number of SaaS installations in hospitals and pharmacies in 2020.
  • In this note, we share our thoughts on the company’s business, financials, and operating metrics.
detail (9-minute read)
WHAT’S TRENDING
logo
Logo
Top 5%
Clarence Chu
APAC IPOs & Placements
Aequitas Research
EquitiesEquity Capital Markets

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our t... 

x